0001472091 2026-10-14 2026-10-14 0001472091 1 2026-10-14 2026-10-14 shares iso4217:USD shares iso4217:USD pure S-3 S-3 PDS Biotechnology Corporation false Equity Common Stock, par value $0.00033 per share true 110001540 1.03 113301586.2 0.000087 9857.24 113301586.2 9857.24 0 0 9857.24 <table style="font-size: 12pt; border-spacing: 0px; border-collapse: collapse; width: 100%;"> <tr style="height: 0px; font-size: 0px;"><td style="width: 1%;"> </td><td style="width: 1%;"> </td><td style="width: 98%;"> </td></tr><tr style="vertical-align: top;"> <td style="padding: 0px 0pt; font-size: 10pt;"> <div style="margin-bottom: 4pt;"> 1 </div> </td><td style="padding: 0px 0pt; font-size: 10pt;"> <div style="margin-bottom: 4pt;"> (1) </div> </td> <td style="padding: 0px 5.4pt 0px 5px; text-align: left; font-size: 10pt; vertical-align: top;"> <div style="margin-bottom: 4pt;">Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement also covers any additional securities that may be offered or issued in connection with any stock dividend, stock split, recapitalization or similar transaction.</div> </td> </tr><tr style="vertical-align: top;"> <td style="font-size: 10pt;"> </td><td style="padding: 0px 0pt; font-size: 10pt;"> <div style="margin-bottom: 4pt;"> (2) </div> </td> <td style="padding: 0px 5.4pt 0px 5px; text-align: left; font-size: 10pt; vertical-align: top;"> <div style="margin-bottom: 4pt;">Pursuant to Rule 457(c) under the Securities Act, and solely for the purpose of calculating the registration fee, the proposed maximum offering price per share is $1.03, which is the average of the high and low prices of the registrant's common stock, par value $0.00033 per share (“Common Stock”) on October 8, 2026, on the Nasdaq Capital Market.</div> </td> </tr><tr style="vertical-align: top;"> <td style="font-size: 10pt;"> </td><td style="padding: 0px 0pt; font-size: 10pt;"> <div style="margin-bottom: 4pt;"> (3) </div> </td> <td style="padding: 0px 5.4pt 0px 5px; text-align: left; font-size: 10pt; vertical-align: top;"> <div style="margin-bottom: 4pt;">Consists of (i) 16,502,870 shares of Common Stock issued to the selling stockholders in a private placement and (ii) up to 93,498,670 shares of Common Stock issuable upon the exercise of warrants issued or issuable to the selling stockholders in such private placement.</div> </td> </tr> </table> N/A N/A 0001472091 EX-FILING FEES